OpenScience.ink

2 weeks ago • Clinical & experimental optometry

Use of GLP-1 receptor drugs and sudden non-artery-related vision loss: an example caseGLP-1 receptor agonist exposure and non-arteritic anterior ischaemic optic neuropathy: an illustrative case.

Article

2 weeks ago • Cureus

Comparing Incretin-Based Treatments and Weight-Loss Surgery for Obesity and Type 2 Diabetes: Effects on Blood Sugar, Heart, Liver, Weight, and Quality of LifeIncretin-Based Therapies Versus Bariatric and Metabolic Surgery for Obesity and Type 2 Diabetes Mellitus: A Head-to-Head Systematic Review of Glycaemic, Cardiovascular, Hepatic, Weight, and Quality-of-Life Outcomes.

Article

2 weeks ago • Cancer control : journal of the Moffitt Cancer Center

Links Between Diabetes Drugs Called GLP-1 Receptor Agonists and Cancer Risk: A Review and AnalysisAssociations Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Cancer Risk: A Systematic Review and Meta-Analysis.

📖 Top 20% JournalSystematic Review

2 weeks ago • The Journal of the American Academy of Orthopaedic Surgeons

Effects and Considerations of Glucagon-like Peptide-1 Receptor Agonists in Joint Replacement SurgeryThe Effect of Glucagon-like Peptide-1 Receptor Agonists in Total Joint Arthroplasty: Implications, Complications, and Considerations.

Article

2 weeks ago • Diabetes, obesity & metabolism

Combining a Virtual GLP-1 Program and Exercise Support to Improve Body Composition During GLP-1 Weight LossQuality Plus Quantity: Evaluation of a Virtual GLP-1 Programme With Physical Activity Support to Promote Healthy Body Composition Change During GLP-1 Weight Loss.

Article

2 weeks ago • Diabetes therapy : research, treatment and education of diabetes and related disorders

Combined SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Link to Heart Attacks and Strokes in Type 2 DiabetesEffect of Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists on Myocardial Infarction and Stroke in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

📖 Top 20% JournalSystematic Review

2 weeks ago • Journal of diabetes and its complications

Semaglutide and empagliflozin effects on blood vessel health markers in people with type 2 diabetesEffects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial.

📖 Top 20% JournalArticle

2 weeks ago • Kidney360

Metabolic Changes After Sugar Test and Insulin Treatment in Chronic Kidney DiseaseMetabolomic Responses to Oral Glucose Tolerance Test and Hyperinsulinemic-euglycemic Clamp in CKD.

📖 Top 20% JournalArticle

2 weeks ago • The American journal of gastroenterology

Do Patients Taking GLP-1 Medicines Need Longer Fasting Before Liver Stiffness Scans?Do Patients on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Require Longer Fasting Prior to Vibration Controlled Transient Elastography?

Article

2 weeks ago • Case reports in endocrinology

One-Sided Graves' Disease Appearing During Tirzepatide Treatment in a Person with DiabetesUnilateral Graves' Disease Developing During Treatment With Tirzepatide in a Patient With Diabetes: A Case Report.

Article

2 weeks ago • Journal of diabetes investigation

Type 1 Diabetes and Obesity: How They Affect the Body and Treatment OptionsType 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications.

📖 Top 20% JournalArticle

2 weeks ago • Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Guide to Weight Loss Medicines and Practical Tips for PatientsOverview of weight loss medicines and practical advice for patients.

Article

2 weeks ago • General psychiatry

Higher natural levels of glucagon-like peptide-1 linked to brain inflammation and amyloid buildup in Alzheimer's diseaseElevated endogenous glucagon-like peptide-1 as a novel Alzheimer's disease biomarker associated with neuroinflammation and Aβ pathology.

🎖️ Top 10% JournalArticle

2 weeks ago • Aesthetic plastic surgery

Psychosocial Effects and Appearance Expectations in Women Having Body Shaping After Weight Loss from GLP-1 Compared to After Weight Loss SurgeryCritical Insights on "Psychosocial Outcomes and Aesthetic Expectations in Female Patients Undergoing Body Contouring After GLP-1-Induced Weight Loss: A Prospective Pilot Comparative Study with Post-Bariatric Patients".

📖 Top 20% JournalLetter

2 weeks ago • Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Tirzepatide’s links to changes in sleep apnea measures based on starting patient traitsAssociation of tirzepatide with changes in OSA-related measures based on baseline characteristics - post hoc analyses of SURMOUNT-OSA.

Randomized Controlled Trial

2 weeks ago • JAMA pediatrics

Gallbladder Problems and Treatment with GLP-1 Medicines in Teens and Young AdultsBiliary Events and GLP-1 Receptor Agonist Therapy in Adolescents and Young Adults.

🥇 Top 1% JournalArticle

2 weeks ago • Endocrinology, diabetes & metabolism

Patterns of Weight Regain After Stopping Semaglutide or Tirzepatide TreatmentWeight Regain Trajectories After Discontinuation of Semaglutide or Tirzepatide: A Reconstructed Aggregate-Data Bayesian Longitudinal Meta-Analysis.

📖 Top 20% JournalMeta-Analysis

2 weeks ago • Journal of primary care & community health

Awareness, Confidence, and Use of Combined GLP-1 and GIP/GLP-1 Medicines Among Healthcare Providers and PharmacistsAssessing Awareness, Confidence and Utilization of Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists Among Healthcare Clinicians and Pharmacists: A Comprehensive Survey Study.

📖 Top 20% JournalObservational Study

2 weeks ago • Clinical obesity

Tirzepatide versus Semaglutide for Weight Loss in Adults with Overweight or Obesity: A Comparison StudyComparative Efficacy of Tirzepatide Versus Semaglutide for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis of Head-to-Head Studies.

📖 Top 30% JournalSystematic Review

2 weeks ago • Annals of internal medicine

How Well and How Safely Weight-Loss Drugs Targeting Glucagon-like Peptide-1 Work in Adults Without DiabetesEfficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.

🥈 Top 2% JournalArticle

2 weeks ago • Journal of internal medicine

New treatments for fatty liver disease and how they could be used in healthcareUpcoming therapies for steatotic liver disease: Translating breakthroughs into clinical practice.

🥉 Top 5% JournalArticle

2 weeks ago • British journal of pharmacology

Oleoylethanolamide's potential for treating obesity and related health problemsThe ongoing oleoylethanolamide story: Therapeutic implications in the control of obesity and its comorbidities.

Article

2 weeks ago • Annals of internal medicine

Tirzepatide lowers blood sugar and weight more than intensified usual care after 2 years in adults with early uncontrolled type 2 diabetesIn adults with early uncontrolled T2D, tirzepatide vs. intensified conventional care reduced HbA1c levels and weight at 2 y.

🥈 Top 2% JournalArticle

2 weeks ago • Gut and liver

Current and New Treatments for Fatty Liver Disease Linked to Metabolic ProblemsMetabolic Dysfunction-Associated Steatotic Liver Disease: Current Treatment Strategies and Novel Therapies.

🎖️ Top 10% JournalArticle

2 weeks ago • JCEM case reports

Lack of response to tirzepatide followed by response to semaglutide in people with moderate obesityTirzepatide non-response with subsequent semaglutide response in class 2 obesity.

Case Reports

2 weeks ago • Nature communications

Heart and blood vessel outcomes of two diabetes drugs in kidney failure patients with heart failureCardiovascular outcome of glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor on end-stage kidney disease patients with heart failure: an emulated target trial in patients with diabetes.

🥈 Top 2% JournalRandomized Controlled Trial

2 weeks ago • Cardiovascular diabetology. Endocrinology reports

Which types of heart failure may benefit from GLP-1 receptor agonists?Which heart failure phenotypes benefit from GLP-1 receptor agonists?

Letter

2 weeks ago • Cureus

Multiple Body System Benefits of Low-Dose GLP-1 TreatmentMultisystem Benefits of GLP-1 Microdosing: A Narrative Review.

Article

2 weeks ago • Cureus

Links Between Semaglutide, a Glucagon-Like Peptide-1 Drug, and Irregular Heartbeats: A Review of Overlapping StudiesGlucagon-Like Peptide-1 Receptor Agonists, Semaglutide, and Atrial Fibrillation: An Umbrella Review With Methodological Appraisal of Overlapping Meta-Analyses.

Article

2 weeks ago • Cureus

Retatrutide from Online Sources May Worsen Diabetic Ketoacidosis in a Type 1 Diabetes Patient with Shigella InfectionOnline-Sourced Retatrutide Complicating Impending Diabetic Ketoacidosis in a Patient With Type 1 Diabetes and Concurrent Shigella Gastroenteritis.

Case Reports

← prevpage 9 of 14next →

Latest GLP-1 Therapies Research Papers